Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01131572 · ClinicalTrials.gov registry record · Phase 2
N-acetylcysteine in Bulimia Nervosa
A Phase 2 study, sponsored by Lindner Center of HOPE.
- Terminated
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT01131572 is a Phase 2 study that was terminated before completion, run by Lindner Center of HOPE. The registered enrollment target is 11 participants.
The verdict
NCT01131572, a Phase 2 study, was terminated before completion, sponsored by Lindner Center of HOPE.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study tests NAC in the treatment of Bulimia Nervosa.
Interventions
- DRUG N-acetylcysteine NAC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01131572
The ClinicalTrials.gov registry entry for NCT01131572 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindner Center of HOPE, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which N-acetylcysteine NAC is the first listed.
NCT01131572 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01131572 about?
NCT01131572 is a clinical study titled "N-acetylcysteine in Bulimia Nervosa". This study tests NAC in the treatment of Bulimia Nervosa.
What is the current status of trial NCT01131572?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2010-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01131572?
The interventions under investigation include: N-acetylcysteine NAC (DRUG).
Who is sponsoring clinical trial NCT01131572?
This trial is sponsored by Lindner Center of HOPE, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.